Scotia Capital Inc. Taro Pharmaceutical Industries LTD Transaction History

Scotia Capital Inc.

  • $17.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$97.82 - $116.09 $260,690 - $309,379
-2,665 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$95.91 - $107.26 $12,947 - $14,480
135 Added 5.34%
2,665 $263,000
Q4 2017

Feb 13, 2018
BUY
$104.5 - $126.38 $264,385 - $319,741
2,530
2,530 $265,000

Others Institutions Holding TARO

# of Institutions
9
Shares Held
17K
Call Options Held
0
Put Options Held
0
View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

TARO Quotes by TradingView
  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Scotia Capital Inc. Portfolio

Follow Scotia Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email